Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 23 min ago
PreprintAll rights reservedbioRxiv

Engineering potent avian GPR25 agonists using an ostrich CXCL17 gene relic

  1. 1Tongji University

Related

  1. Engineering a multifunctional LL37-TP5 hybrid peptide with potent antimicrobial endotoxin-neutralizing and anti-inflammatory properties
    Baseer Ahmad, Kiran Khurshid, Wei Xubiao +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  2. Engineering a production platform for the potent antipseudomonal antibiotic mureidomycin A by reprogramming the pacidamycin biosynthetic gene cluster.
    Panagiota-Hanna Koutsandrea, Richard SonnengrĂ¼n, Nils Hauck +9
    Microbial cell factoriesPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCPMC
  3. Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C
    ESC heart failurePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Programmed Remote Cyano Migration Yields Cyanamides as Potent Ferroptosis Inducers
    Peng Xu, Zhijie Deng
    ACS Central SciencePeer-reviewedCC BY 4.0Full textGeneral medicineCrossref
  5. The Novel Organic Arsenical PZ2 Exhibits Potent Anti-T-ALL Activity via ROS-Dependent Apoptosis and GABARAPL1-Induced Autophagic Cell Death
    Xian Zhang, Zhuping Chen, Yujiao Liu +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
BibTeX
@misc{yu2026engineering,
  title = {{Engineering potent avian GPR25 agonists using an ostrich CXCL17 gene relic}},
  author = {J. Yu and H.-Z. Li and J.-J. Wang and Y.-L. Liu and Z.-Y. Guo},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.14.759250},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.14.759250v1},
}
RIS
TY  - UNPB
TI  - Engineering potent avian GPR25 agonists using an ostrich CXCL17 gene relic
AU  - J. Yu
AU  - H.-Z. Li
AU  - J.-J. Wang
AU  - Y.-L. Liu
AU  - Z.-Y. Guo
PY  - 2026
DA  - 2026/10/14
PB  - bioRxiv
DO  - 10.64898/2026.10.14.759250
UR  - https://www.biorxiv.org/content/10.64898/2026.10.14.759250v1
ER  -